Recently Viewed
Clear All$9.87
$0.18
(1.82%)
As on 22-Nov-2022 15:58EDT
Value Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$175 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$-10 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
65.8
P/B Ratio
1.4
Industry P/E
--
EV/EBITDA
-34.4
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
14,301,000
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Frazier Lifesciences Acquisition Corp (FLAC)
| 1.2 | -1.4 | -0.6 | 0.5 | -- | -- | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Frazier Lifesciences Acquisition Corp (FLAC)
|
9.9 | 175.2 | 0.0 | -3.6 | -- | -- | 65.8 | 1.4 |
| 9.9 | 292.0 | 0.0 | -3.2 | -- | -- | -- | 4.2 |
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in... the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington. Read more
CEO & Chairman
Dr. James N. Topper M.D., Ph.D.
CEO & Chairman
Dr. James N. Topper M.D., Ph.D.
Headquarters
Seattle, WA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Frazier Lifesciences Acquisition Corp (FLAC) is $9.87 (NASDAQ) as of 22-Nov-2022 15:58 EDT. Frazier Lifesciences Acquisition Corp (FLAC) has given a return of 0.51% in the last 1 years.
The P/E ratio of Frazier Lifesciences Acquisition Corp (FLAC) is 65.80 times as on 23-Nov-2022.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
The 52-week high and low of Frazier Lifesciences Acquisition Corp (FLAC) are Rs -- and Rs -- as of 04-Apr-2026.
Frazier Lifesciences Acquisition Corp (FLAC) has a market capitalisation of $ 175 Mln as on 23-Nov-2022. As per SEBI classification, it is a company.
Before investing in Frazier Lifesciences Acquisition Corp (FLAC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.